Digital blood pressure monitor market seen reaching $2.22 billion by 2030

The digital or electrical sphygmomanometer market is projected to rise from $1.28 billion in 2025 to $1.43 billion in 2026, with growth tied to hypertension, telemedicine and home monitoring. The Business Research Company says the market could reach $2.22 billion by 2030 as demand shifts toward portable, automatic and upper-arm devices.

Why it matters: - The market is being shaped by rising hypertension, more chronic disease management and a stronger push for home-based blood pressure checks. - Growth in telemedicine is making connected blood pressure monitoring more useful for remote care and ongoing cardiovascular management. - The sector is gaining attention because blood pressure monitoring is a core tool for early detection and prevention of cardiovascular disease.

What happened: - The Business Research Company released a report on the digital or electrical sphygmomanometer market. - The market is projected to grow from $1.28 billion in 2025 to $1.43 billion in 2026, a 12.0% compound annual growth rate. - The report forecasts the market will reach $2.22 billion by 2030, implying an 11.6% compound annual growth rate. - North America held the largest market share in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - A digital or electrical sphygmomanometer electronically measures blood pressure and displays the result digitally. - The device typically includes an inflatable cuff and a pressure sensor. - The report links recent growth to higher hypertension rates, more lifestyle-related disease, broader primary healthcare coverage, stronger awareness of blood pressure monitoring and wider access to digital medical devices. - The forecast through 2030 reflects aging populations, rising demand for home health monitoring, earlier detection of cardiovascular disease, growth in ambulatory care services and higher healthcare spending on chronic illness. - Expected product trends include more home blood pressure monitoring, greater use of fully automatic models, stronger demand for upper-arm devices, more portable and compact products and more routine preventive checkups. - Digital sphygmomanometers are positioned as useful for consistent monitoring and data recording, especially in home settings. - The U.S. Centers for Disease Control and Prevention reported that high blood pressure was a primary or contributing factor in 664,470 U.S. deaths in 2023. - The Australian Bureau of Statistics reported that 83.5% of males used telehealth services in 2023-24, up from 78.6% the year before.

Between the lines: - The report points to a market shift from clinic-only use toward home and remote monitoring. - Telehealth adoption is increasing the value of devices that can capture readings outside the doctor’s office and feed them into ongoing care. - The emphasis on automatic, portable and upper-arm devices suggests buyers want simpler products that fit routine use.

What's next: - The market’s next phase appears tied to how quickly home monitoring, telemedicine and chronic disease management keep expanding. - Product makers are likely to focus on compact devices, automation and preventive-care use cases as demand grows. - The report also highlights new 2026 features including market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, hotspot infographics and updated graphics and tables.

The bottom line: - Blood pressure monitoring is becoming more decentralized, and that shift is expected to keep lifting demand for digital sphygmomanometers through 2030.